Reactive Airway Disease
10
0
0
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (10)
A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department
A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma
Diagnosing Respiratory Disease in Children Using Cough Sounds 2
Diagnosing Respiratory Disease in Children Using Cough Sounds
The Leaky Lung Test
A Study of Tobacco Smoke and Children With Respiratory Illnesses
Nasal Findings in Reactive Airway Diseases
Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma
Comparison of Asthma Programs for Schools
Comparison of Oral Dexamethasone Doses in Asthma Exacerbation